20 research outputs found

    Lesion of the nipple-areola complex in patients with breast cancer

    No full text
    The article presents data about the lesion of the nipple-areola complex in breast cancer. In 2015-2016 surgical treatment was performed in 101 breast cancer patients, different in size but with the mandatory removal of the nipple-areola complex. There are analyzed the dependence of the lesion of the nipple-areola complex from histological types of breast cancer, molecular subtypes, multicentricity, the location of tumor in the breast. The most significant criterion was the dependence of the lesion of the nipple-areola complex from the distance between tumor node and the nipple

    Lesion of the nipple-areola complex in patients with breast cancer

    No full text
    The article presents data about the lesion of the nipple-areola complex in breast cancer. In 2015-2016 surgical treatment was performed in 101 breast cancer patients, different in size but with the mandatory removal of the nipple-areola complex. There are analyzed the dependence of the lesion of the nipple-areola complex from histological types of breast cancer, molecular subtypes, multicentricity, the location of tumor in the breast. The most significant criterion was the dependence of the lesion of the nipple-areola complex from the distance between tumor node and the nipple

    ΠŸΠ΅Ρ€Π²ΠΈΡ‡Π½Π°Ρ фолликулярная ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ° ΠΏΠΎΡ‡ΠΊΠΈ. ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΎΠ΅ наблюдСниС ΠΈ ΠΎΠ±Π·ΠΎΡ€ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹

    No full text
    Primary thyroid-like follicular renal cell carcinoma is an extremely rare type of renal cell cancer with low malignancy potential and relatively good prognosis. It has not been included into the World Health Organization classification of renal tumors. This tumor is characterized by morphology similar to primary thyroid follicular cancer, but with different immune phenotype, which is important for morphological diagnosis. Surgery has been recognized as the only curative treatment. We describe our own observation of follicular renal carcinoma in a 68-year old man, in whom renal tumor was identified during his regular examination due to past colon cancer. The disease was asymptomatic. The patient had elective laparoscopic nephrectomy. At pathological assessment, the tumor looked like a follicular thyroid neoplasm. Immunohistochemistry revealed no expression of RCC, TTF-1, thyroglobulin, CD-10, synaptophysin, and chromogranin A. The differential diagnosis included metastatic primary thyroid malignancy as the most probable diagnosis, as well as highly differentiated neuroendocrine tumor and the so-called β€œthyroid kidney” that might occur in long-standing chronic pyelonephritis. Conclusion: The case of primary follicular renal carcinoma illustrates that this rare renal tumor is heterogeneous both in its structure and tumor cell immunophenotypes. Longer follow-up and accumulation of larger numbers of the disease is needed. This would allow for a more objective assessment of its prevalence in the population, of its clinical characteristics and morphological variability.ΠŸΠ΅Ρ€Π²ΠΈΡ‡Π½Π°Ρ фолликулярная ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ° ΠΏΠΎΡ‡ΠΊΠΈ (Π°Π½Π³Π». primary thyroid-like follicular renal cell carcinoma) - Ρ‡Ρ€Π΅Π·Π²Ρ‹Ρ‡Π°ΠΉΠ½ΠΎ Ρ€Π΅Π΄ΠΊΠΈΠΉ Π²Π°Ρ€ΠΈΠ°Π½Ρ‚ ΠΏΠΎΡ‡Π΅Ρ‡Π½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ Ρ€Π°ΠΊΠ° с Π½ΠΈΠ·ΠΊΠΈΠΌ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»ΠΎΠΌ злокачСствСнности ΠΈ ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ Ρ…ΠΎΡ€ΠΎΡˆΠΈΠΌ ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·ΠΎΠΌ, Π½Π΅ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ Π² ΠΊΠ»Π°ΡΡΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΡŽ ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ ΠΏΠΎΡ‡ΠΊΠΈ ВсСмирной ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ здравоохранСния. Π­Ρ‚Π° ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒ характСризуСтся сходным морфологичСским строСниСм с ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½Ρ‹ΠΌ фолликулярным Ρ€Π°ΠΊΠΎΠΌ Ρ‰ΠΈΡ‚ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹, Π½ΠΎ ΠΎΡ‚Π»ΠΈΡ‡Π½Ρ‹ΠΌ ΠΎΡ‚ Π½Π΅Π΅ ΠΈΠΌΠΌΡƒΠ½ΠΎΡ„Π΅Π½ΠΎΡ‚ΠΈΠΏΠΎΠΌ, Ρ‡Ρ‚ΠΎ Π²Π°ΠΆΠ½ΠΎ для морфологичСской диагностики. Π₯ирургичСский ΠΌΠ΅Ρ‚ΠΎΠ΄ ΠΏΡ€ΠΈΠ·Π½Π°Π½ СдинствСнным ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ лСчСния. Описано собствСнноС наблюдСниС фолликулярной ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΡ‹ ΠΏΠΎΡ‡ΠΊΠΈ Ρƒ ΠΌΡƒΠΆΡ‡ΠΈΠ½Ρ‹ 68 Π»Π΅Ρ‚, Ρƒ ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ³ΠΎ ΠΏΡ€ΠΈ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½ΠΎΠΌ обслСдовании ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρƒ Ρ€Π°ΠΊΠ° толстой кишки Π² Π°Π½Π°ΠΌΠ½Π΅Π·Π΅ ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Π° ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒ ΠΏΠΎΡ‡ΠΊΠΈ. Π—Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΏΡ€ΠΎΡ‚Π΅ΠΊΠ°Π»ΠΎ бСссимптомно. Π’ ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΌ порядкС Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Π° лапароскопичСская нСфрэктомия. ΠŸΡ€ΠΈ патологоанатомичСском исслСдовании ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒ Π±Ρ‹Π»Π° ΠΏΠΎΡ…ΠΎΠΆΠ° Π½Π° Ρ„ΠΎΠ»Π»ΠΈΠΊΡƒΠ»ΡΡ€Π½ΡƒΡŽ ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒ Ρ‰ΠΈΡ‚ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹. ΠŸΡ€ΠΈ иммуногистохимичСском исслСдовании Π² ΠΊΠ»Π΅Ρ‚ΠΊΠ°Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ отсутствовала экспрСссия RCC, TTF-1, Ρ‚ΠΈΡ€Π΅ΠΎΠ³Π»ΠΎΠ±ΡƒΠ»ΠΈΠ½Π°, CD-10, синаптофизина, Ρ…Ρ€ΠΎΠΌΠΎΠ³Ρ€Π°Π½ΠΈΠ½Π° А. Π”ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΠ°Π»ΡŒΠ½Π°Ρ диагностика ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡŒ Π² ΠΏΠ΅Ρ€Π²ΡƒΡŽ ΠΎΡ‡Π΅Ρ€Π΅Π΄ΡŒ с мСтастазом ΠΎΡ‚ ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ Ρ‰ΠΈΡ‚ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹, с высокодиффСрСнцированной нСйроэндокринной ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒΡŽ, Π° Ρ‚Π°ΠΊΠΆΠ΅ с Ρ‚Π°ΠΊ Π½Π°Π·Ρ‹Π²Π°Π΅ΠΌΠΎΠΉ Ρ‚ΠΈΡ€Π΅ΠΎΠΈΠ΄Π½ΠΎΠΉ ΠΏΠΎΡ‡ΠΊΠΎΠΉ, Ρ€Π°Π·Π²ΠΈΠ²Π°ΡŽΡ‰Π΅ΠΉΡΡ ΠΏΡ€ΠΈ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΌ хроничСском Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠΈ ΠΏΠΈΠ΅Π»ΠΎΠ½Π΅Ρ„Ρ€ΠΈΡ‚Π°. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½Π½ΠΎΠ΅ Π½Π°ΠΌΠΈ наблюдСниС ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ фолликулярной ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΡ‹ ΠΏΠΎΡ‡ΠΊΠΈ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΠ΅Ρ‚ ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ этот Ρ€Π΅Π΄ΠΊΠΈΠΉ Π²Π°Ρ€ΠΈΠ°Π½Ρ‚ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΏΠΎΡ‡Π΅ΠΊ Π½Π΅ΠΎΠ΄Π½ΠΎΡ€ΠΎΠ΄Π΅Π½ ΠΈ ΠΏΠΎ особСнностям строСния, ΠΈ ΠΏΠΎ ΠΈΠΌΠΌΡƒΠ½ΠΎΡ„Π΅Π½ΠΎΡ‚ΠΈΠΏΡƒ ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ. НСобходимо ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΠ΅ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° наблюдСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΈ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ большСго числа случаСв Π΄Π°Π½Π½ΠΎΠ³ΠΎ заболСвания. Π­Ρ‚ΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ Π±ΠΎΠ»Π΅Π΅ ΠΎΠ±ΡŠΠ΅ΠΊΡ‚ΠΈΠ²Π½ΠΎ ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ частоту встрСчаСмости этих ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ Π² популяции, ΠΈΡ… клиничСскиС характСристики ΠΈ ΠΌΠΎΡ€Ρ„ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Π²Π°Ρ€ΠΈΠ°Π±Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ

    Π§ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎ-мноТСствСнного синхронного двустороннСго Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½Ρ‹Ρ… ΠΆΠ΅Π»Π΅Π· ΠΊ Π½Π΅ΠΎΠ°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠΉ Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ

    No full text
    Objective β€” to evaluate the sensitivity of multiple primary bilateral synchronous breast cancer (BC) to neoadjuvant drug therapy. Subject and methods. The investigation enrolled 14 patients with multiple primary synchronous BC who received drug treatment at the first stage of combined treatment. Eleven patients underwent 6 to 8 cycles of neoadjuvant polychemotherapy (NAPCT); targeted therapy drugs were simultaneously added to taxane-containing regimens in 2 patients with HER2-positive tumors. Results. The mean age of the patients was 44.3Β±13.8 years, which was substantially younger than that of the total population of BC patients. The histological pattern of tumor nodules in both mammary glands was the same in 11 patients and the tumors in the mammary glands were different in 3 patients. Therapeutic pathomorphism (TP) was absent in 2 (8.3%) cases; it was poorly expressed (grade 1) in 4 (12.5%) cases, grades 2, 3, and 4 were seen in 7 (29.2%), 6 (16.7%), and 9 (33.3%), respectively. None of the 7 patients with the edematous-infiltrative form of BC achieved grade 4 TP despite its different biological types. The immunohistochemical study showed that edematous infiltrative BC was presented as a luminal type in 5 cases, as a triple-negative one in 1 case, and as a luminal type B, HER2-positive in 1 case. Nine of the 28 cases achieved complete TP in the primary tumor, but only one patient had it in both tumors with different biological types. Conclusion. In most cases, the reaction of synchronous tumors to NAPCT did not coincide in the same patient. A complete pathomorphism was most common in the triple negative type (33.3Β±16.6%), which corresponds to the current ideas on the behavior of this aggressive biological type of BC. The authors consider it necessary to further study the reaction of synchronous tumors to neoadjuvant therapy and to accumulate clinical materials for the reliable confirmation of the findings, which is important for the development of an adequate treatment policy and theoretical knowledge of the pathogenesis of drug sensitivity/resistance of breast tumors.ЦСль исслСдования β€” ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎ-мноТСствСнного двустороннСго синхронного Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½Ρ‹Ρ… ΠΆΠ΅Π»Π΅Π· (Π ΠœΠ–) ΠΊ Π½Π΅ΠΎΠ°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠΉ лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡ΠΈΠ»ΠΈ 14 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎ-мноТСствСнным синхронным Π ΠœΠ–, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Π½Π° I этапС ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ лСчСния ΠΏΠΎΠ»ΡƒΡ‡ΠΈΠ»ΠΈ лСкарствСнноС Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅. Π£ 11 Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΡ‚ 6 Π΄ΠΎ 8 курсов Π½Π΅ΠΎΠ°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠΉ ΠΏΠΎΠ»ΠΈΡ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ (НАПΠ₯Π’), Ρƒ 2 с НER2-ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½Ρ‹ΠΌΠΈ опухолями ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎ ΠΊ таксансодСрТащим Ρ€Π΅ΠΆΠΈΠΌΠ°ΠΌ добавляли ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Ρ‹ Ρ‚Π°Ρ€Π³Π΅Ρ‚Π½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π‘Ρ€Π΅Π΄Π½ΠΈΠΉ возраст Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… составил 44,3Β±13,8 Π³ΠΎΠ΄Π°, Ρ‡Ρ‚ΠΎ сущСствСнно мСньшС ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ с ΠΎΠ±Ρ‰Π΅ΠΉ популяциСй Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π ΠœΠ–. ГистологичСская Ρ„ΠΎΡ€ΠΌΠ° ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… ΡƒΠ·Π»ΠΎΠ² Ρƒ 11 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ Π±Ρ‹Π»Π° ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΠΎΠΉ Π² ΠΎΠ±Π΅ΠΈΡ… ΠΌΠΎΠ»ΠΎΡ‡Π½Ρ‹Ρ… ΠΆΠ΅Π»Π΅Π·Π°Ρ…, Ρƒ 3 ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ Π² ΠΌΠΎΠ»ΠΎΡ‡Π½Ρ‹Ρ… ΠΆΠ΅Π»Π΅Π·Π°Ρ… ΠΎΡ‚Π»ΠΈΡ‡Π°Π»ΠΈΡΡŒ. Π›Π΅Ρ‡Π΅Π±Π½Ρ‹ΠΉ ΠΏΠ°Ρ‚ΠΎΠΌΠΎΡ€Ρ„ΠΎΠ· (Π›ΠŸ) отсутствовал Π² 2 (8,3%) случаях, Π±Ρ‹Π» слабо Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½ (I ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ) Π² 4 (12,5%), II ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ Π±Ρ‹Π»Π° Π² 7 (29,2%), III ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ β€” Π² 6 (16,7%), IV ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ β€” Π² 9 (33,3%) случаях. Из 7 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с ΠΎΡ‚Π΅Ρ‡Π½ΠΎ-ΠΈΠ½Ρ„ΠΈΠ»ΡŒΡ‚Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠΉ Ρ„ΠΎΡ€ΠΌΠΎΠΉ Π ΠœΠ– Π½ΠΈ Ρƒ ΠΎΠ΄Π½ΠΎΠΉ Π½Π΅ Π±Ρ‹Π» достигнут Π›ΠŸ IV стСпСни, нСсмотря Π½Π° Π΅Π³ΠΎ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Π΅ биологичСскиС Ρ‚ΠΈΠΏΡ‹. По Π΄Π°Π½Π½Ρ‹ΠΌ Π˜Π“Π₯-исслСдования ΠΎΡ‚Π΅Ρ‡Π½ΠΎ-ΠΈΠ½Ρ„ΠΈΠ»ΡŒΡ‚Ρ€Π°Ρ‚ΠΈΠ²Π½Ρ‹ΠΉ Π ΠœΠ– Π² 5 случаях Π±Ρ‹Π» прСдставлСн Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΌ Ρ‚ΠΈΠΏΠΎΠΌ, Π² 1 случаС β€” Ρ‚Ρ€ΠΎΠΉΠ½Ρ‹ΠΌ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½Ρ‹ΠΌ ΠΈ Π² 1 β€” Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΌ Ρ‚ΠΈΠΏΠΎΠΌ Π’, HER2-ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½Ρ‹ΠΌ. ΠŸΠΎΠ»Π½Ρ‹ΠΉ Π›ΠŸ Π² ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ Π±Ρ‹Π» достигнут Π² 9 ΠΈΠ· 28 случаСв, Π½ΠΎ лишь Ρƒ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠΈ Π² ΠΎΠ±Π΅ΠΈΡ… опухолях с Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹ΠΌΠΈ биологичСскими Ρ‚ΠΈΠΏΠ°ΠΌΠΈ. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. РСакция синхронных ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ Ρƒ ΠΎΠ΄Π½ΠΎΠΉ ΠΈ Ρ‚ΠΎΠΉ ΠΆΠ΅ больной Π½Π° НАПΠ₯Π’ Π² Π±ΠΎΠ»ΡŒΡˆΠΈΠ½ΡΡ‚Π²Π΅ случаСв Π½Π΅ совпадала. НаиболСС часто ΠΏΠΎΠ»Π½Ρ‹ΠΉ ΠΏΠ°Ρ‚ΠΎΠΌΠΎΡ€Ρ„ΠΎΠ· ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ ΠΏΡ€ΠΈ Ρ‚Ρ€ΠΎΠΉΠ½ΠΎΠΌ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½ΠΎΠΌ Ρ‚ΠΈΠΏΠ΅ (33,3Β±16,6%), Ρ‡Ρ‚ΠΎ соотвСтствуСт соврСмСнным прСдставлСниям ΠΎ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ этого агрСссивного биологичСского Ρ‚ΠΈΠΏΠ° Π ΠœΠ–. ΠœΡ‹ ΠΏΠΎΠ»Π°Π³Π°Π΅ΠΌ, Ρ‡Ρ‚ΠΎ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎ дальнСйшСС ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΠ΅ особСнностСй Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ синхронных ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ Π½Π° Π½Π΅ΠΎΠ°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠ΅ воздСйствиС, Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ клиничСского ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° для достовСрного подтвСрТдСния ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… Π΄Π°Π½Π½Ρ‹Ρ…, Ρ‡Ρ‚ΠΎ Π²Π°ΠΆΠ½ΠΎ для Π²Ρ‹Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ Π°Π΄Π΅ΠΊΠ²Π°Ρ‚Π½ΠΎΠΉ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ лСчСния ΠΈ Π½Π°Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ тСорСтичСских Π·Π½Π°Π½ΠΈΠΉ ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½Π΅Π·Π° лСкарствСнной Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ/рСзистСнтности ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹

    Π€Π˜Π›Π―Π Π˜ΠžΠ— ΠœΠžΠ›ΠžΠ§ΠΠžΠ™ Π–Π•Π›Π•Π—Π«. ΠšΠžΠœΠŸΠ›Π•ΠšΠ‘ΠΠΠ― ЛУЧЕВАЯ Π”Π˜ΠΠ“ΠΠžΠ‘Π’Π˜ΠšΠ И Π›Π•Π§Π•ΠΠ˜Π•

    No full text
    F ilariasis is a tropical disease caused by the parasite Dirofilaria repens. The lesion of the breast occurs in 10%. Purpose. To present a clinical case of a woman with breast pathology. Materials and methods. The condition did not manifest clinically. Detection of atypical cyst in the breast using ultrasound technology and its subsequent biopsy allowed to confirm the pathology. Results. The possibilities of an integrated approach in the diagnosis of breast lesions and minimally invasive treatment of a patient with a parasitic lesion of the breast are demonstrated.Π€ иляриоз - это тропичСскоС Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Π²Ρ‹Π·Π²Π°Π½Π½ΠΎΠ΅ ΠΏΠ°Ρ€Π°Π·ΠΈΡ‚ΠΎΠΌ Dirofilaria repens. ΠŸΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ встрСчаСтся Π² 10%. ЦСль. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²ΠΈΡ‚ΡŒ клиничСскоС наблюдСниС ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹ с ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. БостояниС клиничСски Π½Π΅ ΠΏΡ€ΠΎΡΠ²Π»ΡΠ»ΠΎΡΡŒ. ВыявлСниС Π°Ρ‚ΠΈΠΏΠΈΡ‡Π½ΠΎΠΉ кисты Π² ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Π΅ с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²Ρ‹Ρ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π°Ρ Π΅Π΅ биопсия ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΈ ΠΏΠΎΠ΄Ρ‚Π²Π΅Ρ€Π΄ΠΈΡ‚ΡŒ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΡŽ. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΡ€ΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡ‚Ρ€ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ возмоТности комплСксного ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π° Π² диагностикС ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ ΠΈ ΠΌΠ°Π»ΠΎΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ лСчСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠΈ с ΠΏΠ°Ρ€Π°Π·ΠΈΡ‚Π°Ρ€Π½Ρ‹ΠΌ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹

    Breast filariasis. Complex diagnostic and treatment [Π€Π˜Π›Π―Π Π˜ΠžΠ— ΠœΠžΠ›ΠžΠ§ΠΠžΠ™ Π–Π•Π›Π•Π—Π«. ΠšΠžΠœΠŸΠ›Π•ΠšΠ‘ΠΠΠ― ЛУЧЕВАЯ Π”Π˜ΠΠ“ΠΠžΠ‘Π’Π˜ΠšΠ И Π›Π•Π§Π•ΠΠ˜Π•]

    No full text
    Filariasis is a tropical disease caused by the parasite Dirofilaria repens. The lesion of the breast occurs in 10%. Purpose. To present a clinical case of a woman with breast pathology. Materials and methods. The condition did not manifest clinically. Detection of atypical cyst in the breast using ultrasound technology and its subsequent biopsy allowed to confirm the pathology. Results. The possibilities of an integrated approach in the diagnosis of breast lesions and minimally invasive treatment of a patient with a parasitic lesion of the breast are demonstrated. Β© 2019 Russian Electronic Journal of Radiology. All rights reserved

    New procedures for determining resection margins during organ-sparing surgery in patients with breast cancer

    No full text
    Breast cancer (BC) occupies a leading place in the structure of cancers among the female population worldwide. The number of breast cancer patients currently tends to increase in the 30–45-year-old group. Organ-sparing treatment (OST) is recommended to improve quality of life in the patients. The operation involves the excision of a segment with a breast lump, but achievement of negative resection margins is mandatory. The latest data show that to achieve the purity of resection margins, indents of up to 2 mm and 1 mm are currently recommended for ductal carcinoma in situ and an invasive form, respectively. Despite the existing data on the safety and benefits of OST, 20 to 30% of patients with invasive or non-invasive BC usually undergo a reoperation. The increased number of repeated resections, and especially mastectomies, leads to severe psychological and physical traumas in women, substantially worsening the quality of life. It is important to correctly mark resection margins during surgery. The paper presents up-to-date methods to examine resection margins intraoperatively. It includes techniques, such as micro-CT, Cherenkov luminescence imaging, radiofrequency spectroscopy-based β€œMargin Probe”, and fluorescence imaging. The use of the most promising techniques and their long-term results are described. Β© A group of authors, 2020

    Treatment options of breast cancer patients after breast-conserving surgery with positive margins R1

    No full text
    Introduction: in organ-preserving operations for breast cancer, the risk of recurrence is associated with many factors, including positive resection margins. The article presents data from the literature, which considers the risk of relapse depending on the positive, close and negative edges of resection. The purpose of this study was to increase the effectiveness of treatment of breast cancer patients after organ-preserving operations with positive resection edges. Materials and methods: the study included 1219 patients with breast cancer who underwent organ-preserving and oncoplastic resections of the breast. Urgent cytological and histological intraoperative examination of the resection edges is analyzed in detail, and the marking of the resection edges is presented. The clinical and morphological characteristics of patients with breast cancer at R0 and Rl are presented. Results: positive edge of Rl resection was diagnosed in 53 cases, which was 4,3Β±2,8%, in oncoplastic resections in 4,1Β±1,1%, in classical breast resections in 4,6Β±0,7% (p>0,05). In the group of patients with Rl, multicentricity of the tumor was diagnosed in 11,1Β±5,3%, and monocentric tumor was detected in 4,1 Β±0,5%. Further tactics in the case of Rl detection were as follows: in 21 cases, radiation therapy was performed on the breast, in 32 cases, re - operation: resection of the edges - in 14 patients, radical mastectomy - in 9 patients, subcutaneous mastectomy with simultaneous reconstruction with autologous flaps or endoprostheses - in 9 patients. In the group of patients with re-operation, 43,7% of the planned study showed no signs of malignancy, 56,3% showed a residual tumor, while 31.3% were diagnosed with cancer in situ. So in the case of resection of the edges in 5 cases, a residual tumor was diagnosed in the resected edges, which was 35,7%, and in the case of mastectomy, a residual tumor was detected in 68,4%. Re-operation in R1 after oncoplastic resections was performed in 71,4%, and in classical resections in 56,4%, which correlates with the literature data. Conclusion: in two groups of patients after organ-preserving operations with positive resection margins, no local recurrence was detected during the follow-up period from 1 to 60 months, and distant metastases, namely, lesions of the bones of the skeleton, were diagnosed in 2 patients. Thus, with a positive edge of resection after organ-preserving surgery, both surgical treatment and radiation therapy can be performed. Although the presence of a tumor in the colored edges of resection is clearly associated with a high frequency of local relapses, but the relapse is also influenced by the biological characteristics of the tumor and the body. Individual characteristics are the basis of tumor biology, and the extent of their influence on long-term results is not reduced due to the wide surgical margins of resection. Β© 2020 Izdatel'stvo Meditsina. All rights reserved

    LAPAROSCOPIC RESECTION OF THE HORSESHOE KIDNEY FOR RENAL CELL CARCINOMA

    No full text
    Renal fusion is one of the most common kidney anomalies. The most frequent is horseshoe kidney, characterized by a fusion of the poles (typically the lower poles) of the kidneys. We described a clinical case of a malignant tumor in the right half of the horseshoe kidney (stage 1 cancer, CT1aN0M0) in a man aged 65 years, who underwent laparoscopic resection. It was shown that laparoscopy is no less efficient than open surgery. However, in planning the operation, it is necessary to use spiral computed tomography for three-dimensional reconstruction of the organ and identification of its anatomical features caused by aberrant blood supply to horseshoe kidney

    ΠžΡΠΎΠ±Π΅Π½Π½ΠΎΡΡ‚ΠΈ Π΄ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ диагностики слизистого ΠΈ слизистого микропапиллярного Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹

    No full text
    Objective - to analyze the clinical and pathomorphological characteristics of types A and B mucinous breast cancer (BC) and micropapillary carcinoma with obvious mucus production. Subject and methods. The paper analyzes the results of examination and treatment in 38 patients. Early-stage (I and IIA) BC was diagnosed in 81.6% of cases in the study. The patients’ mean age was 60.2Β±7.9 years (range 33-78). The distribution of the patients according to the stages of BC was as follows: 18 (47.4%) patients with Stage I BC, 13 (34.2%) with IIA stage, 3 (7.9%) with IIB stage, 2 (5.3%) with IIIA stage, 1 (2.6%) with IIIB stage, 1 (2.6%) with IIIC stage. The lymph node status was pNin 33 cases with no lymph node metastases in mucinous BC and pNin 5 cases with invasive micropapillary carcinoma (IMPC) of the breast. The multicentricity of tumor nodules was diagnosed in 4 (10.5%) cases; the number of tumor nodules was from 2 to 3 in the breast, as well as in all cases in mucinous BC. The distribution of the patients according to the molecular biological type of a tumor was as follows: luminal A tumor in 21 (58.3%) cases, luminal B Her2-negative cancer in 11 (30.5%), luminal B Her2-positive tumor in 3 (8, 3%), and triple negative BC in 1 (2.9%). There was a triple negative BC type in 1 case of IMPC of the breast, a luminal B Her2-positive type in 3 cases of mucinous BC, and luminal types of the tumor were diagnosed in the other cases. Results. Lymph node metastases were found in 5 (13.2%) cases. In this investigation, all the patients with lymph node metastases had one type of cancer - invasive mucinous micropapillary carcinoma. At the same time, mucinous micropapillary carcinoma was confirmed by biopsy only in 1 female patient. During the follow-up, 38 patients with mucinous and mucinous micropapillary BC were found to have distant metastases in none of the groups. The investigation revealed the following relationship of lymph node metastatic spread: the metastases were diagnosed as T1 in 10% of cases, T2 in 15.4%, and T3 in 25%. Conclusion. The task of a pathologist is to identify and correctly differentiate invasive micropapillary carcinoma with obvious mucus production from simple mucinous carcinomas types A and B in the preoperative period of the examination. So, only a study of sentinel lymph nodes can be performed in only simple mucinous breast carcinoma; axillary lymphadenectomy should be carried out in micropapillary carcinoma with obvious mucus production. Treatment policy for invasive micropapillary BC with obvious mucus production should be more aggressive, while that for mucinous cancer is minimal.ЦСль исслСдования - ΠΏΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ клиничСскиС ΠΈ патоморфологичСскиС особСнности слизистого Ρ€Π°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ (Π ΠœΠ–) Ρ‚ΠΈΠΏΠ° А ΠΈ Π’ ΠΈ микропапиллярного Ρ€Π°ΠΊΠ° с Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½Ρ‹ΠΌ слизСобразованиСм. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΏΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ обслСдования ΠΈ лСчСния 38 Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…. Π’ исслСдовании Π² 81,6% случаСв диагностированы Π½Π°Ρ‡Π°Π»ΡŒΠ½Ρ‹Π΅ (I ΠΈ IIА) стадии Π ΠœΠ–. Π‘Ρ€Π΅Π΄Π½ΠΈΠΉ возраст ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ 60,2Β±7,9 Π³ΠΎΠ΄Π° (33-78 Π»Π΅Ρ‚). РаспрСдСлСниС ΠΏΠΎ стадиями Π ΠœΠ–: I - 18 (47,4%) ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ, IIA - 13 (34,2%), IIB - 3 (7,9%), IIIA - 2 (5,3%), IIIB - 1 (2,6%), IIIΠ‘ - 1 (2,6%). БостояниС лимфатичСских ΡƒΠ·Π»ΠΎΠ²: Ρ€N0 - 33 случая, ΠΏΡ€ΠΈ этом мСтастазы отсутствовали Π² лимфатичСских ΡƒΠ·Π»Π°Ρ… ΠΏΡ€ΠΈ слизистом Π ΠœΠ–, Ρ€N1-3 - 5 случаСв ΠΏΡ€ΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ микропапиллярной ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ΅ (ИМПК) Π ΠœΠ–. ΠœΡƒΠ»ΡŒΡ‚ΠΈΡ†Π΅Π½Ρ‚Ρ€ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… ΡƒΠ·Π»ΠΎΠ² диагностирована Π² 4 (10,5%) случаях, число ΡƒΠ·Π»ΠΎΠ² Π² ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Π΅ ΠΎΡ‚ 2 Π΄ΠΎ 3 ΠΈ Π²ΠΎ всСх случаях ΠΏΡ€ΠΈ слизистом Π ΠœΠ–. РаспрСдСлСниС Π² зависимости ΠΎΡ‚ молСкулярно-биологичСского Ρ‚ΠΈΠΏΠ° ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅Π΅: Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ Ρ‚ΠΈΠΏ А Π² 21 (58,3%) случаС, Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ Ρ‚ΠΈΠΏ Π’ Her2-Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½Ρ‹ΠΉ Π² 11 (30,5%), Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ Ρ‚ΠΈΠΏ Π’ Her2-ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½Ρ‹ΠΉ Π² 3 (8,3%), Ρ‚Ρ€ΠΎΠΉΠ½ΠΎΠΉ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½Ρ‹ΠΉ Ρ‚ΠΈΠΏ Π² 1 (2,9%). ΠŸΡ€ΠΈ ИМПК Π ΠœΠ– Π² 1 случаС выявлСн Ρ‚Ρ€ΠΎΠΉΠ½ΠΎΠΉ Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½Ρ‹ΠΉ Ρ‚ΠΈΠΏ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ, Π° ΠΏΡ€ΠΈ слизистом Π ΠœΠ– Π² 3 случаях - Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ Ρ‚ΠΈΠΏ Π’ НСr2-ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½Ρ‹ΠΉ, Π² ΠΎΡΡ‚Π°Π»ΡŒΠ½Ρ‹Ρ… случаях диагностированы Π»ΡŽΠΌΠΈΠ½Π°Π»ΡŒΠ½Ρ‹Π΅ Ρ‚ΠΈΠΏΡ‹ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠœΠ΅Ρ‚Π°ΡΡ‚Π°Π·Ρ‹ Π² лимфатичСских ΡƒΠ·Π»Π°Ρ… ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Ρ‹ Π² 5 (13,2%) случаях. Π’ исслСдовании всС ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠΈ с мСтастазами Π² лимфатичСских ΡƒΠ·Π»Π°Ρ… ΠΈΠΌΠ΅Π»ΠΈ ΠΎΠ΄ΠΈΠ½ Ρ‚ΠΈΠΏ Ρ€Π°ΠΊΠ° - ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡƒΡŽ ΠΌΡƒΡ†ΠΈΠ½ΠΎΠ·Π½ΡƒΡŽ ΠΌΠΈΠΊΡ€ΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡ€Π½ΡƒΡŽ ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΡƒ. ΠŸΡ€ΠΈ этом Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Ρƒ 1 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠΈ ΠΏΠΎ Π΄Π°Π½Π½Ρ‹ΠΌ биопсии Π±Ρ‹Π»Π° ΠΏΠΎΠ΄Ρ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½Π° муцинозная микропапиллярная ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ°. Π—Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ наблюдСния Ρƒ 38 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ со слизистым ΠΈ ΠΌΡƒΡ†ΠΈΠ½ΠΎΠ·Π½Ρ‹ΠΌ микропапиллярным Π ΠœΠ– ΠΎΡ‚Π΄Π°Π»Π΅Π½Π½Ρ‹Ρ… мСтастазов Π½Π΅ ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½ΠΎ Π½ΠΈ Π² ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π³Ρ€ΡƒΠΏΠΏ. Π’ исслСдовании выявлСна ΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π°Ρ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡ‚ΡŒ мСтастазирования Π² лимфатичСских ΡƒΠ·Π»Π°Ρ…: ΠΏΡ€ΠΈ T1 диагностированы мСтастазы Π² 10% случаСв, ΠΏΡ€ΠΈ T2 - Π² 15,4%, ΠΏΡ€ΠΈ T3 - Π² 25%. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π—Π°Π΄Π°Ρ‡Π° Π²Ρ€Π°Ρ‡Π°-ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΎΠ°Π½Π°Ρ‚ΠΎΠΌΠ° - Π²Ρ‹ΡΠ²ΠΈΡ‚ΡŒ ΠΈ ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΠΎ Π΄ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡƒΡŽ ΠΌΠΈΠΊΡ€ΠΎΠΏΠ°ΠΏΠΈΠ»Π»ΡΡ€Π½ΡƒΡŽ ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΡƒ с Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½Ρ‹ΠΌ слизСобразованиСм ΠΎΡ‚ простых ΠΌΡƒΡ†ΠΈΠ½ΠΎΠ·Π½Ρ‹Ρ… ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌ Ρ‚ΠΈΠΏΠ° A ΠΈ B Π² ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ обслСдования. Π’Π°ΠΊ, Π² случаС Ρ‚ΠΎΠ»ΡŒΠΊΠΎ простой ΠΌΡƒΡ†ΠΈΠ½ΠΎΠ·Π½ΠΎΠΉ ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΡ‹ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ ΠΌΠΎΠΆΠ½ΠΎ Π²Ρ‹ΠΏΠΎΠ»Π½ΡΡ‚ΡŒ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ исслСдованиС ΡΠΈΠ³Π½Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ², Π° ΠΏΡ€ΠΈ микропапиллярном Ρ€Π°ΠΊΠ΅ с Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½Ρ‹ΠΌ слизСобразованиСм Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚ΡŒ ΠΏΠΎΠ΄ΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΡƒΡŽ Π»ΠΈΠΌΡ„Π°Π΄Π΅Π½ΡΠΊΡ‚ΠΎΠΌΠΈΡŽ. ЛСчСбная Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠ° ΠΏΡ€ΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΌ микропапиллярном Ρ€Π°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ с Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½Ρ‹ΠΌ слизСобразованиСм Π΄ΠΎΠ»ΠΆΠ½Π° Π±Ρ‹Ρ‚ΡŒ Π±ΠΎΠ»Π΅Π΅ агрСссивной, Ρ‚ΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ ΠΏΡ€ΠΈ слизистом Ρ€Π°ΠΊΠ΅ ΠΎΠ½Π° минимальна
    corecore